Treatment sequencing in oncology: balancing clinical trial and real-world evidence Foreword

被引：8
作者：
Caffo, Orazio [1 ]
机构：
[1] Santa Chiara Hosp, Dept Med Oncol, Trento, Italy
来源：
FUTURE ONCOLOGY | 2019年 / 15卷 / 25期
关键词：
D O I：
10.2217/fon-2019-0415
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2887 / 2889
页数：3
相关论文
共 14 条
  • [1] Sequencing strategies in the new treatment landscape of prostate cancer
    Caffo, Orazio
    Maines, Francesca
    Kinspergher, Stefania
    Veccia, Antonello
    Messina, Carlo
    [J]. FUTURE ONCOLOGY, 2019, 15 (25) : 2967 - 2982
  • [2] Emerging strategies in the initial management of locally advanced rectal cancer
    Gately, Lucy
    Wong, Hui-Li
    Tie, Jeanne
    Wong, Rachel
    Lee, Margaret
    Lee, Belinda
    Jalali, Azim
    Gibbs, Peter
    [J]. FUTURE ONCOLOGY, 2019, 15 (25) : 2955 - 2965
  • [3] Optimizing outcomes and treatment sequences in EGFR mutation-positive non-small-cell lung cancer: recent updates
    Girard, Nicolas
    [J]. FUTURE ONCOLOGY, 2019, 15 (25) : 2983 - 2997
  • [4] How can better identification of T790M help to inform treatment sequencing decisions in EGFR mutation-positive non-small-cell lung cancer?
    Hochmair, Maximilian J.
    [J]. FUTURE ONCOLOGY, 2019, 15 (25) : 2895 - 2898
  • [5] Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: updated analysis of the observational GioTag study
    Hochmair, Maximilian J.
    Morabito, Alessandro
    Hao, Desiree
    Yang, Cheng-Ta
    Soo, Ross A.
    Yang, James C-H
    Gucalp, Rasim
    Halmos, Balazs
    Wang, Lara
    Maerten, Angela
    Cufer, Tanja
    [J]. FUTURE ONCOLOGY, 2019, 15 (25) : 2905 - 2913
  • [6] Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: an observational study
    Hochmair, Maximilian J.
    Morabito, Alessandro
    Hao, Desiree
    Yang, Cheng-Ta
    Soo, Ross A.
    Yang, James C-H
    Gucalp, Rasim
    Halmos, Balazs
    Wang, Lara
    Golembesky, Amanda
    Maerten, Angela
    Cufer, Tanja
    [J]. FUTURE ONCOLOGY, 2018, 14 (27) : 2861 - 2874
  • [7] Ke X, 2017, FRONTIERS LAB MED, V1, P69, DOI [10.1016/j.flm.2017.06.001, DOI 10.1016/J.FLM.2017.06.001]
  • [8] The Current Landscape of Immune Checkpoint Inhibition for Solid Malignancies
    Keung, Emily Z.
    Wargo, Jennifer A.
    [J]. SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2019, 28 (03) : 369 - +
  • [9] Khozin S, 2017, JNCI-J NATL CANCER I, V109, P11
  • [10] Targeted agents or immuno-oncology therapies as first-line therapy for BRAF-mutated metastatic melanoma: a real-world study
    Luke, Jason J.
    Ghate, Sameer R.
    Kish, Jonathan
    Lee, Choo Hyung
    McAllister, Lindsay
    Mehta, Sonam
    Ndife, Briana
    Feinberg, Bruce A.
    [J]. FUTURE ONCOLOGY, 2019, 15 (25) : 2933 - 2942
12